Exelixis Announces May 3rd Webcast of First Quarter 2012 Financial Results Conference Call
April 19 2012 - 4:09PM
Business Wire
Exelixis, Inc. (NASDAQ:EXEL) will release its first quarter 2012
financial results on Thursday, May 3, 2012, after the markets
close. The announcement will be followed by a live webcast at 5:00
p.m. EDT/ 2:00 p.m. PDT. During the webcast, Exelixis management
will discuss the Company’s financial results, financial outlook and
development program and plans for cabozantinib, and also provide a
general business update. The webcast may be accessed in the Event
Calendar page under Investors at http://www.exelixis.com.
An archived replay of the webcast will be available on the Event
Calendar page under Investors at http://www.exelixis.com and via
phone until 11:59 p.m. EDT on June 3, 2012. Access numbers for the
phone replay are: 888-286-8010 (domestic) and 617-801-6888
(international); the passcode is 33847783.
About Exelixis
Exelixis, Inc. is a biotechnology company committed to
developing small molecule therapies for the treatment of cancer.
Exelixis is focusing its proprietary resources and development
efforts exclusively on cabozantinib (XL184), its most advanced
product candidate, in order to maximize the therapeutic and
commercial potential of this compound. Exelixis believes
cabozantinib has the potential to be a high-quality,
broadly-active, differentiated pharmaceutical product that can make
a meaningful difference in the lives of patients. Exelixis has also
established a portfolio of other novel compounds that it believes
have the potential to address serious unmet medical needs, many of
which are being advanced by partners as part of collaborations. For
more information, please visit the company's web site at
http://www.exelixis.com.
Exelixis (NASDAQ:EXEL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Exelixis (NASDAQ:EXEL)
Historical Stock Chart
From Apr 2023 to Apr 2024